ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,135.20
      -0.51%
      Dow Jones
      39,065.26
      -1.53%
      Brent Oil
      81.25
      -0.34%
      Bitcoin
      67,794.78
      -1.89%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      05/23/20245:00PMBusiness WireGenmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:GMABGenmab AS
      05/23/20245:00PMBusiness WireMerck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
      05/23/20245:00PMGlobeNewswire Inc.IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual MeetingNASDAQ:INABIN8bio Inc
      05/23/20245:00PMBusiness WireLegend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHANASDAQ:LEGNLegend Biotech Corporation
      05/23/20245:00PMBusiness WireSOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual MeetingNASDAQ:CADLCandel Therapeutics Inc
      05/23/20245:00PMGlobeNewswire Inc.Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual MeetingTG:2GHMerus NV
      05/23/20245:00PMGlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
      05/23/20245:00PMGlobeNewswire Inc.Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024NASDAQ:EVAXEvaxion Biotech AS
      05/23/20245:00PMBusiness WireObsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual MeetingNASDAQ:MURAMural Oncology PLC
      05/23/20245:00PMBusiness WireDentalcorp Announces Annual General Meeting Voting ResultsTSX:DNTLdentalcorp Holdings Ltd
      05/23/20245:00PMGlobeNewswire Inc.Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
      05/23/20245:00PMGlobeNewswire Inc.MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENTNASDAQ:MAQCMaquia Capital Acquisition Corporation
      05/23/20245:00PMGlobeNewswire Inc.Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual MeetingNASDAQ:KYMRKymera Therapeutics Inc
      05/23/20245:00PMBusiness WireKlaviyo to Present at the William Blair Growth Stock ConferenceNYSE:KVYOKlaviyo Inc
      05/23/20245:00PMGlobeNewswire Inc.Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual MeetingNASDAQ:MRUSMerus NV
      05/23/20245:00PMBusiness WireOrca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Timbercreek Financial Declares May 2024 DividendTSX:TFTimbercreek Financial Corp
      05/23/20245:00PMBusiness WireNeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid TumorsTSX:THTheratechnologies Inc
      05/23/20245:00PMGlobeNewswire Inc.Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
      05/23/20245:00PMBusiness WireMenarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual MeetingTG:2GHMerus NV
      05/23/20245:00PMBusiness WireIambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting
      05/23/20245:00PMBusiness WireXspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinib
      05/23/20245:00PMBusiness WireEMD Serono to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
      05/23/20245:00PMGlobeNewswire Inc.Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:REPLReplimune Group Inc
      05/23/20245:00PMGlobeNewswire Inc.Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual MeetingTG:GE9Genmab AS
      05/23/20245:00PMGlobeNewswire Inc.NVIDIA Announces Upcoming Event for Financial CommunityNASDAQ:NVDANVIDIA Corporation